Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: A systematic review

BACKGROUND AND AIM: DM patients' antibody response after the COVID-19 vaccine is still unknown amid the COVID-19 vaccination rollout. This study aimed to explore the SARS-CoV-2 antibody response or seropositivity among DM patients following the COVID-19 vaccine administration. METHODS: We perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Soetedjo, Nanny Natalia M., Iryaningrum, Maria Riastuti, Lawrensia, Sherly, Permana, Hikmat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776339/
https://www.ncbi.nlm.nih.gov/pubmed/35104750
http://dx.doi.org/10.1016/j.dsx.2022.102406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776339/
https://www.ncbi.nlm.nih.gov/pubmed/35104750
http://dx.doi.org/10.1016/j.dsx.2022.102406

Ejemplares similares